![PE131000: α-GalNAc-PEG3-Alkyne label-new 5-bis(acetyloxy)-6-[(acetyloxy)methyl]-3-acetamidooxan-2-yl]oxy}pentanoic acid](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/PE131000-R.svg?v=1713192675)
Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
5-bis(acetyloxy)-6-[(acetyloxy)methyl]-3-acetamidooxan-2-yl]oxy}pentanoic acid
1 / Epilepsy And Bipolar Disorder (Mood Disorder) / Lamotrigine-13C d3 / 6-(2
Galβ1-4GlcNAc) building block
/ 4-Methylumbelliferyl α(GlcNAcβ(1-4)Man) / 4-MU-α(GlcNAcβ(1-4)Man)
36 / IgA1 synthetic Hinge Region peptide fragment from Val222 to Cys241 with glycosylation (α-GalNAc) at Thr228
PE131000: α-GalNAc-PEG3-Alkyne label-new 5-bis(acetyloxy)-6-[(acetyloxy)methyl]-3-acetamidooxan-2-yl]oxy}pentanoic acidC17H29NO9 391. 41 An D N acetylgalactosamine (GalNAc) ligand equipped with a terminal alkyne through a hydrophilic PEG3 spacer. The alkyne couples to azide functionalized partners via copper catalyzed azide alkyne cycloaddition (CuAAC), forming stable 1,2,3 triazole linkages. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the asialoglycoprotein receptor (ASGPR), which is highly expressed on
US$ 15.49
US$ 150.00
US$ 102.50
US$ 19.99
US$ 112.50
![Phage the Untouchable [Secret Lair Drop Series] GG10](https://cdn.shopify.com/s/files/1/0687/6358/2762/files/0492401b-5e4a-5d03-b82d-27f815a9feb4.jpg?v=1756234842)
